Technology News and Research

RSS

Using Light Scattering to Characterize Protein-Nucleic Acid Interactions

Harnessing the interactions between DNA, RNA, and proteins holds much promise for detecting biomarkers, diagnosing disease, and improving cancer-targeting therapeutics. Quantifying these interactions is essential for understanding and controlling their biomolecular mechanisms.

From Waters | Wyatt Technology 26 Jun 2019

Stability Testing of Therapeutic Proteins using DLS and Machine Learning

PIPPI scientists from different fields are developing methodologies, tools, and databases to guide the rational formulation of robust protein-based therapeutics. Their overall goal is to develop a database to guide product formulation development.

From Waters | Wyatt Technology 26 Jun 2019

New class of radiopharmaceuticals offer fresh perspective on cancer imaging, theranostics

Research presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging describes a new class of radiopharmaceuticals, named radiohybrids, that offer a fresh perspective on cancer imaging and radioligand therapy.

26 Jun 2019

Machine learning can be a modern approach in cognitive brain health assessment

Worldwide, about 44 million people are living with Alzheimer's disease or a related form of dementia.

26 Jun 2019

Role of biochip advancements in next-generation sequencing

Biochips are essentially tiny laboratories designed to function inside living organisms, and they are driving next-generation DNA sequencing technologies.

26 Jun 2019

New model could help find new cancer drugs, speed up traffic, combat disease

A new mathematical model of the structure of networks could help find new cancer drugs, speed up traffic flow and combat sexually transmitted disease.

26 Jun 2019

LSU Health researchers to investigate link between breast cancer and obesity in real time

Frank Lau, MD, Associate Professor in the Section of Plastic and Reconstructive Surgery at LSU Health New Orleans School of Medicine, has been awarded a grant by the Southeastern Society of Plastic Surgeons to improve the care and research of breast cancer and obesity.

25 Jun 2019

Researchers develop simple blood test for detecting Alzheimer’s disease

Researchers from Lund University, together with the Roche pharmaceutical company, have used a method to develop a new blood marker capable of detecting whether or not a person has Alzheimer's disease.

25 Jun 2019

Scientists develop accurate, wearable voice recognition device

A team of scientists has developed a flexible and wearable voice sensor that accurately recognizes the user’s voice, without being affected by the surrounding voice.

25 Jun 2019

Laser light helps identify tumors

It can take up to four weeks before patients can be sure whether the entire tumor has been removed during cancer surgery.

25 Jun 2019

Sleep quality linked to memory problems in new study

A new study has shown that poor sleep quality and varying bedtimes reduce the ability to recall information from the past in older adults.

25 Jun 2019

Daily outdoor activity reduces progression of nearsightedness in children

New research suggests that adding 30 minutes of daily outdoor activity reduces the progression of nearsightedness, called myopia, in children if the activity is continued.

25 Jun 2019

Atomwise and Enamine launch 10 billion compound virtual drug screening initiative

Atomwise, Inc. today announced the launch of a 10 billion compound AI-powered virtual drug screening initiative, the 10-to-the-10 program, in collaboration with Enamine Ltd., the world’s largest chemical supplier.

25 Jun 2019

Lab Innovations launches free advance registration for all visitors

Lab Innovations, the UK’s only trade show dedicated to the laboratory industry, has launched free advance registration for all visitors at www.lab-innovations.com.

From Lab Innovations 25 Jun 2019

PhoreMost and C4XD sign neurodegeneration drug discovery collaboration agreement

PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, and C4X Discovery Holdings plc, a pioneering drug discovery company, today announced they have signed a neurodegeneration drug discovery collaboration agreement.

From PhoreMost 25 Jun 2019

AXT enhances cellular research product portfolio with solutions from StemBioSys

AXT is pleased to announce it has further enhanced its cellular research product portfolio through the addition of stem cell solutions from StemBioSys. The recently signed agreement will see AXT distribute StemBioSys’ unique solutions to researchers in Australia and New Zealand.

From AXT Pty Ltd 25 Jun 2019